Trademark: 79016579
Word
ADILNA
Status
Dead
Status Code
404
Status Date
Sunday, July 12, 2015
Serial Number
79016579
Registration Number
3204166
Registration Date
Tuesday, January 30, 2007
Mark Type
5000
Filing Date
Monday, July 11, 2005
Published for Opposition
Tuesday, November 14, 2006
Cancellation Date
Sunday, July 12, 2015

Trademark Owner History

Classifications
5 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANUESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SUIJFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ARABOGALACTANE SULPHATE, QUINIDINE PHENYIJETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEPPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q10, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE, IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMTJS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TAMSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, LEDRONIC ACID
The mark ADILNA does not identify a living individual.

Trademark Events
Jan 31, 2016
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Jan 31, 2016
Death Of International Registration
Jun 5, 2015
Total Invalidation Processed By The Ib
Nov 6, 2014
Generic Madrid Transaction Sent To Ib
Nov 6, 2014
Generic Madrid Transaction Created
May 27, 2014
Total Invalidation Of Reg Ext Protection Created
Sep 27, 2013
Cancelled Section 71
Nov 3, 2012
Change Of Name/Address Rec'd From Ib
Jul 2, 2009
Change Of Owner Received From Ib
May 23, 2008
Final Decision Transaction Processed By Ib
Aug 27, 2007
Final Disposition Notice Sent To Ib
Aug 27, 2007
Final Disposition Processed
Aug 21, 2007
Final Disposition Notice Created, To Be Sent To Ib
Jan 30, 2007
Registered-Principal Register
Nov 14, 2006
Published For Opposition
Oct 25, 2006
Notice Of Publication
Sep 22, 2006
Law Office Publication Review Completed
Sep 15, 2006
Assigned To Lie
Sep 4, 2006
Approved For Pub - Principal Register
Aug 17, 2006
Amendment From Applicant Entered
Jul 24, 2006
Correspondence Received In Law Office
Jul 24, 2006
Paper Received
Jul 14, 2006
Teas Change Of Correspondence Received
Feb 17, 2006
Refusal Processed By Ib
Jan 31, 2006
Non-Final Action Mailed - Refusal Sent To Ib
Jan 31, 2006
Non-Final Action (Ib Refusal) Prepared For Review
Jan 30, 2006
Non-Final Action Written
Jan 30, 2006
Assigned To Examiner
Nov 14, 2005
New Application Entered In Tram
Nov 10, 2005
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24